EBRO 2017

Trials of radiotherapy after mastectomy and axillary dissection

1772 pN4+ women

RT: Significant benefit

Locoregional recurrence first Any first recurrence Breast cancer mortality

8.8%

9.3 %

Years since randomisation Years since randomisation

Years since randomisation